Sunday, June 23, 2013 2:30:36 PM
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=88599931
and the vaccine created using the immunocytokine 2aG4-IL2 for breast cancer. Here is the KM plot from this paper:
Enhancing the potency of a whole-cell breast cancer vaccine in mice with an antibody-IL-2 immunocytokine that targets exposed phosphatidylserine
Huang X, Ye D, Thorpe PE.
http://www.ncbi.nlm.nih.gov/pubmed/21557977
"By all means let's be open-minded, but not so open-minded that our brains drop out." - Richard Dawkins
Recent CDMO News
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
